FranΓ§aisπ See the interactive version (live chart) β
For Onto Innovation, we replayed every analyst price target of the past 12 months and measured the real outcome: 60% were profitable, average return +48% (73 calls). At 3 months: +7% average return (57% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Needham | 16 | 44% | +45% |
| B. Riley Securities | 15 | 60% | +54% |
| Benchmark | 15 | 73% | +65% |
| Stifel | 10 | 80% | +48% |
| Oppenheimer | 7 | 43% | +35% |
Is Onto Innovation overvalued, and is it a good time to buy Onto Innovation right now? If you're wondering, here's a recap to make up your own mind: Onto Innovation's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Onto Innovation | Sector median (Information Technology) |
|---|---|---|
| P/E | 110.0 | 39.4 |
| Forward P/E | 25.1 | 20.6 |
| Net margin | 12% | 16% |
π Onto Innovation trades above its sector median (110.0 vs 39.4) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
The analyst consensus on Onto Innovation (ONTO) is "Buy" (30 bullish, 0 bearish calls over 12 months). This is not advice: historically, 60% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $380 (+30% vs $293), ranging from $330 to $450 (10 analysts).
Over 1 year, 60% of analyst targets on Onto Innovation were profitable, for an average return of +48% (across 73 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $380 within 12 months, i.e. +30% vs the current price. The most bullish targets $450, the most cautious $330.
Note: analyst targets are 12-month (median $380, +30%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (60%), and the stock's past trajectory.
Its P/E is 110.0, forward P/E 25.1. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Onto Innovation β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.